TY - JOUR
T1 - Genome-wide association study identifies multiple susceptibility loci for multiple myeloma
AU - Mitchell, Jonathan S
AU - Li, Ni
AU - Weinhold, Niels
AU - Försti, Asta
AU - Ali, Mina
AU - van Duin, Mark
AU - Thorleifsson, Gudmar
AU - Johnson, David C
AU - Chen, Bowang
AU - Halvarsson, Britt-Marie
AU - Gudbjartsson, Daniel F
AU - Kuiper, Rowan
AU - Stephens, Owen W
AU - Bertsch, Uta
AU - Broderick, Peter
AU - Campo, Chiara
AU - Einsele, Hermann
AU - Gregory, Walter A
AU - Gullberg, Urban
AU - Henrion, Marc
AU - Hillengass, Jens
AU - Hoffmann, Per
AU - Jackson, Graham H
AU - Johnsson, Ellinor
AU - Jöud, Magnus
AU - Kristinsson, Sigurður Y
AU - Lenhoff, Stig
AU - Lenive, Oleg
AU - Mellqvist, Ulf-Henrik
AU - Migliorini, Gabriele
AU - Nahi, Hareth
AU - Nelander, Sven
AU - Nickel, Jolanta
AU - Nöthen, Markus M
AU - Rafnar, Thorunn
AU - Ross, Fiona M
AU - da Silva Filho, Miguel Inacio
AU - Swaminathan, Bhairavi
AU - Thomsen, Hauke
AU - Turesson, Ingemar
AU - Vangsted, Annette
AU - Vogel, Ulla
AU - Waage, Anders
AU - Walker, Brian A
AU - Wihlborg, Anna-Karin
AU - Broyl, Annemiek
AU - Davies, Faith E
AU - Thorsteinsdottir, Unnur
AU - Langer, Christian
AU - Hansson, Markus
AU - Kaiser, Martin
AU - Sonneveld, Pieter
AU - Stefansson, Kari
AU - Morgan, Gareth J
AU - Goldschmidt, Hartmut
AU - Hemminki, Kari
AU - Nilsson, Björn
AU - Houlston, Richard S
PY - 2016/7/1
Y1 - 2016/7/1
N2 - Multiple myeloma (MM) is a plasma cell malignancy with a significant heritable basis. Genome-wide association studies have transformed our understanding of MM predisposition, but individual studies have had limited power to discover risk loci. Here we perform a meta-analysis of these GWAS, add a new GWAS and perform replication analyses resulting in 9,866 cases and 239,188 controls. We confirm all nine known risk loci and discover eight new loci at 6p22.3 (rs34229995, P=1.31 × 10(-8)), 6q21 (rs9372120, P=9.09 × 10(-15)), 7q36.1 (rs7781265, P=9.71 × 10(-9)), 8q24.21 (rs1948915, P=4.20 × 10(-11)), 9p21.3 (rs2811710, P=1.72 × 10(-13)), 10p12.1 (rs2790457, P=1.77 × 10(-8)), 16q23.1 (rs7193541, P=5.00 × 10(-12)) and 20q13.13 (rs6066835, P=1.36 × 10(-13)), which localize in or near to JARID2, ATG5, SMARCD3, CCAT1, CDKN2A, WAC, RFWD3 and PREX1. These findings provide additional support for a polygenic model of MM and insight into the biological basis of tumour development.
AB - Multiple myeloma (MM) is a plasma cell malignancy with a significant heritable basis. Genome-wide association studies have transformed our understanding of MM predisposition, but individual studies have had limited power to discover risk loci. Here we perform a meta-analysis of these GWAS, add a new GWAS and perform replication analyses resulting in 9,866 cases and 239,188 controls. We confirm all nine known risk loci and discover eight new loci at 6p22.3 (rs34229995, P=1.31 × 10(-8)), 6q21 (rs9372120, P=9.09 × 10(-15)), 7q36.1 (rs7781265, P=9.71 × 10(-9)), 8q24.21 (rs1948915, P=4.20 × 10(-11)), 9p21.3 (rs2811710, P=1.72 × 10(-13)), 10p12.1 (rs2790457, P=1.77 × 10(-8)), 16q23.1 (rs7193541, P=5.00 × 10(-12)) and 20q13.13 (rs6066835, P=1.36 × 10(-13)), which localize in or near to JARID2, ATG5, SMARCD3, CCAT1, CDKN2A, WAC, RFWD3 and PREX1. These findings provide additional support for a polygenic model of MM and insight into the biological basis of tumour development.
KW - Journal Article
U2 - 10.1038/ncomms12050
DO - 10.1038/ncomms12050
M3 - Journal article
C2 - 27363682
SN - 2041-1723
VL - 7
JO - Nature Communications
JF - Nature Communications
M1 - 12050
ER -